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Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, United StatesDr. Farzad Mostashari currently works as the CEO and Founder
of Aledade Health, a start-up created in 2014 focused on providing
accountable care solutions to small independent primary care
providers. Prior to starting Aledade Health, Dr. Mostashari served
as a Visiting Fellow at the Brookings Institution and from 2011 to
2013 served as the National Coordinator for Health Information
Technology where he coordinated efforts to build a health in-
formation technology infrastructure to accommodate changes in
health reform. Before that, Dr. Mostashari also worked in the New
York City Department of Health and Mental Hygiene as Assistant
Commissioner. Dr. Mostashari is a graduate of Yale Medical School
and trained at the Massachusetts General Hospital in internal
medicine.
Jordan Anderson: You are the CEO and Founder of Aledade. What
inﬂuenced you to offer an accountable care solution to small in-
dependent providers?
Farzad Mostashari: Throughout my career I've been searching
for a way to bring together population health and healthcare.
What I have learned is that you need all the pieces to come to-
gether. You need a business case for population health, you need
tools and technology to understand your population, you need
practice transformation, and you need the non-ﬂashy work of
changing workﬂows and changing culture at the ground level.
That is the mission for Aledade: to go to the primary care providers
– the quarterbacks – who are best-suited for population health
management and to give them everything they need to make
population health worthwhile.
JA: As you are growing the company, how do you evaluate dif-
ferent markets? What makes for a good accountable care market?
FM: Most importantly, there has to be a supply of independent
primary care practitioners who plan to stay independent. More
logistical factors include the availability of admission, discharge,
and transfer notiﬁcations. This information is available in states
like Delaware, Maryland, and New York, and it makes it so much
easier for the primary care providers to be aware of what's hap-
pening with their patients. Many of the considerations regarding
different markets have to do with the current regulations. It is
harder to do well in a state that is already very judicious in terms
of health care costs. We are not exclusively focusing on higher
costs areas, but it is harder to compete in a shared savings model
in Minnesota compared to Florida
JA: As I understand the model, you are not including hospitals as
participants in the ACOs. Is that correct?6/j.hjdsi.2015.04.006
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an_anderson@hms.harvard.eduFM: That is correct and why that matters is that we really want
to focus on the mission of the ACO – to do everything we can to
lower costs. As the ACO focuses on it’s core mission, hospitals
stand to lose revenue from reductions in admissions as well as
potentially unnecessary procedures and diagnostic imaging. This
creates a real tension. Either hospitals will not be wholeheartedly
enthusiastic in reducing admissions or they will try to shore up
referrals to their high cost, high margin lines of business, neither
of which would be in line with our priorities. While I was studying
ACOs at the Brookings Institute, I was initially surprised that
hospital-led ACOs were not nearly as successful as the scrappy
physician-led ACOs. I think that it was in part due to these con-
ﬂicted positions.
That being said, it's absolutely critical for primary care led ACOs
to work with all other parts of the healthcare system that touch
the patient. They need to partner with long-term care, home
health providers, specialists, as well as with hospitals. Hospitals
serve an essential function, but there is a difference between
having partnerships and having a governing role. Where I think
we are in good alignment with hospitals is on readmissions, since
every hospital is actively focused on reducing readmissions.
But our work in Maryland has been very interesting in looking
to the future. Maryland has a Medicare payment waiver that has
allowed them to shift hospital revenue to global budget payments.
Through this mechanism, hospitals have been provided an addi-
tional positive incentive to reduce admissions. This ﬂips the po-
larity of incentive for the hospital in such a way that they really
want to reduce admissions, and the opportunities for collaboration
there are really great.
JA: Shifting to the macro level – how do you see the national
accountable care landscape evolving over the next decade?
FM: Recently the Secretary of Health and Human Services an-
nounced that Medicare is setting a goal of making more than half
of Medicare payments “value-based.” I would expect this change
in payments to help maintain the current momentum in ACO
formation. To achieve this goal, Medicare and private payers must
make alternative payment programs attractive for providers.
But there is also a larger question – what is the ultimate des-
tination for these organizations? Will these organizations even-
tually transition out of accountable care and into full capitation, or
just settle somewhere between fee-for-service and global capita-
tion. I don't think we have a good handle on what the ultimate
structure will look like yet. Currently, the methodology that CMS
has implemented in the Medicare Shared Savings Program to set
historical benchmarks and calculate shared savings has created attp://creativecommons.org/licenses/by/4.0/).
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JA:Medicare is in the process of revising the regulations for the
Medicare Shared Savings Program. What are the most important
changes you would like to see?
FM: There are a couple things that I think would be key
changes. The ﬁrst is the benchmark. The current methodology of
the Medicare Shared Savings Program does not accommodate the
long-term sustainability of ACOs, because you are always trying to
improve upon your previous year’s performance, which will
eventually have diminishing returns. A more sustainable model
would be to change an ACO’s benchmark to include regional
comparators, rather than simply being a historical benchmark. The
second is a move to make accountability more attractive to phy-
sicians. The current two-sided model isn't sufﬁcient, it will be
important for Medicare to create more opportunity for ACOs to
gain from the increased accountability they are taking for these
patients. The third change is around attribution; both the retro-
spective [attributing patients based on previous visits] and pro-
spective [attributing patients based on expected visits] approaches
to attribution are ﬂawed. I would recommend that they combine
the good features of both to create a single stable model where an
ACO knows who their patients are in advance, but they are not
responsible for patients who stop seeing a network physician.
Ultimately this preserves the patient’s choice and allows patients
to opt-out if they would like.
JA: One ﬁnal question. You transitioned from over a decade of
public service to being an entrepreneur. What have been your biggest
challenges and greatest learnings?
FM: Starting Aledade has been a lot easier than running a
federal agency – so that has been a pleasant surprise! The chal-
lenge for any entrepreneur is to understand what the futurepossibilities are. You have to build your company in a way that will
work now, but also when you are 10 or 20 your current size.
You must build your team and your product and your strategy in a
way that can scale. I think that is the most interesting challenge for
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